Skip to main navigation Skip to search Skip to main content

CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC

  • Ada Congrains
  • , Kei Kamide
  • , Tomohiro Katsuya
  • , Osamu Yasuda
  • , Ryousuke Oguro
  • , Koichi Yamamoto
  • , Mitsuru Ohishi
  • , Hiromi Rakugi

Research output: Contribution to journal › Article › peer-review

128 Scopus citations

Abstract

ANRIL is a newly discovered non-coding RNA lying on the strongest genetic susceptibility locus for cardiovascular disease (CVD) in the chromosome 9p21 region. Genome-wide association studies have been linking polymorphisms in this locus with CVD and several other major diseases such as diabetes and cancer. The role of this non-coding RNA in atherosclerosis progression is still poorly understood.In this study, we investigated the implication of ANRIL in the modulation of gene sets directly involved in atherosclerosis. We designed and tested siRNA sequences to selectively target two exons (exon 1 and exon 19) of the transcript and successfully knocked down expression of ANRIL in human aortic vascular smooth muscle cells (HuAoVSMC). We used a pathway-focused RT-PCR array to profile gene expression changes caused by ANRIL knock down. Notably, the genes affected by each of the siRNAs were different, suggesting that different splicing variants of ANRIL might have distinct roles in cell physiology. Our results suggest that ANRIL splicing variants play a role in coordinating tissue remodeling, by modulating the expression of genes involved in cell proliferation, apoptosis, extra-cellular matrix remodeling and inflammatory response to finally impact in the risk of cardiovascular disease and other pathologies.

Original languageEnglish
Pages (from-to)612-616
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume419
Issue number4
DOIs
StatePublished - 23 Mar 2012
Externally publishedYes

Keywords

  • 9p21 Locus
  • ANRIL
  • Atherosclerosis
  • CDKN2BAS
  • VSMC

Fingerprint

Dive into the research topics of 'CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC'. Together they form a unique fingerprint.

Cite this